2seventy bio (MEX:TSVT) Additional Paid-In Capital: MXN15,995.9 Mil(As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TSVT 2seventy bio Inc MEX:TSVT
9 GF Score
Price MXN170.00
View Full Analysis

What is 2seventy bio Additional Paid-In Capital?

2seventy bio MEX:TSVT 9 Additional Paid-In Capital is MXN15,995.9 Mil as of Mar. 2025. GuruFocus rates MEX:TSVT with a GF Score™ of 9/100.


2seventy bio's quarterly additional paid-in capital increased from Sep. 2024 (MXN15,294.2 Mil) to Dec. 2024 (MXN16,250.3 Mil) but then stayed the same from Dec. 2024 (MXN16,250.3 Mil) to Mar. 2025 (MXN15,995.9 Mil).

2seventy bio's annual additional paid-in capital increased from Dec. 2022 (MXN11,833.8 Mil) to Dec. 2023 (MXN13,014.4 Mil) and increased from Dec. 2023 (MXN13,014.4 Mil) to Dec. 2024 (MXN16,250.3 Mil).

2seventy bio Additional Paid-In Capital Related Terms

2seventy bio Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for 2seventy bio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2seventy bio Additional Paid-In Capital Chart

2seventy bio Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial 0.00 8,206.13 11,833.80 13,014.43 16,250.26

2seventy bio Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,806.67 14,180.60 15,294.17 16,250.26 15,995.94
MEX:TSVT
9GF Score
2seventy bio Inc MEX:TSVT
Additional Paid-In Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

2seventy bio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of MXN15,995.9 Mil mean?
2seventy bio (MEX:TSVT) has a Additional Paid-In Capital of MXN15,995.9 Mil as of Mar. 2025. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on 2seventy bio and its competitors.
Is 2seventy bio's Additional Paid-In Capital too high?
2seventy bio's current Additional Paid-In Capital is MXN15,995.9 Mil. Overall, 2seventy bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does 2seventy bio's Additional Paid-In Capital compare to ALMS and TERN?
2seventy bio's Additional Paid-In Capital of MXN15,995.9 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Biotechnology company?
A good Additional Paid-In Capital depends on the Biotechnology industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on 2seventy bio and its competitors. 2seventy bio's current Additional Paid-In Capital is MXN15,995.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2seventy bio stock overvalued right now?
2seventy bio (MEX:TSVT) has a current Additional Paid-In Capital of MXN15,995.9 Mil. The current Additional Paid-In Capital is MXN15,995.9 Mil. 2seventy bio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For 2seventy bio (MEX:TSVT), the current Additional Paid-In Capital is MXN15,995.9 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

2seventy bio Business Description

Address 60 Binney Street, Cambridge, MA, USA, 02142
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
9GF Score

Get the complete analysis for MEX:TSVT

Additional Paid-In Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price